---
category: news
title: "Arctoris Ltd: Arctoris welcomes on board globally recognized experts in Machine Learning, Chemical Computation, and Alzheimer's Disease"
excerpt: "Arctoris Ltd, a tech-enabled biopharma platform company, has appointed three globally recognized experts in Alzheimer's disease, Machine Learning applied to closed loop discovery, and automated chemis"
publishedDateTime: 2022-10-04T09:07:00Z
originalUrl: "https://www.finanznachrichten.de/nachrichten-2022-10/57213736-arctoris-ltd-arctoris-welcomes-on-board-globally-recognized-experts-in-machine-learning-chemical-computation-and-alzheimer-s-disease-004.htm"
webUrl: "https://www.finanznachrichten.de/nachrichten-2022-10/57213736-arctoris-ltd-arctoris-welcomes-on-board-globally-recognized-experts-in-machine-learning-chemical-computation-and-alzheimer-s-disease-004.htm"
type: article
quality: 0
heat: -1
published: false

provider:
  name: Finanznachrichten
  domain: finanznachrichten.de

topics:
  - Machine Learning
  - AI

related:
  - title: "Arctoris welcomes on board globally recognized experts in Machine Learning, Chemical Computation, and Alzheimer’s Disease"
    excerpt: "Arctoris Ltd, a tech-enabled biopharma platform company, has appointed three globally recognized experts in Alzheimer’s disease, Machine Learning applied to closed loop discovery, and automated chemistry as members of its Scientific Advisory Board: Professor John Davis (University of Oxford),"
    publishedDateTime: 2022-10-04T09:03:00Z
    webUrl: "https://www.eagletribune.com/region/arctoris-welcomes-on-board-globally-recognized-experts-in-machine-learning-chemical-computation-and-alzheimer-s/article_13cc7f46-06cb-5178-9337-e546c1ea02b8.html"
    type: article
    provider:
      name: Eagle-Tribune
      domain: eagletribune.com
    quality: 14
    images:
      - url: "https://bloximages.chicago2.vip.townnews.com/eagletribune.com/content/tncms/assets/v3/editorial/9/f7/9f75bc5c-aa81-5c5c-9ec2-29860937e286/633bfa3517a48.image.jpg?crop=1282%2C673%2C180%2C0&resize=1200%2C630&order=crop%2Cresize"
        width: 1200
        height: 630
        isCached: true
  - title: "Experimental Alzheimer’s Drug Slows Cognitive Decline in Large Study"
    excerpt: "The experimental Alzheimer’s disease drug lecanemab slowed the progression of cognitive decline by 27 percent in a large, late-stage clinical trial, the drugmakers Biogen and Eisai said."
    publishedDateTime: 2022-10-05T00:11:00Z
    webUrl: "https://www.everydayhealth.com/alzheimers-disease/experimental-alzheimers-drug-slows-cognitive-decline-in-large-study/"
    type: article
    provider:
      name: Everyday Health
      domain: everydayhealth.com
    quality: 4

secured: "EAQUyGu3uKRNRR8mUt+hkZUVthoROLTxfQtO+kFlX26CuZAi43S+ejr8TEbTSe5FAipe7aJcdF62YqKzt/a2ikFRF2ROFu/p/Sxgv+OtHvKcpb9aXba1tHNHWJNE7XeYW/fVtDHeRXrL0pjfUnm/G7fKro0q/uRPxDNmQPh8uc5anJe31pz+3QB5EM9VWgMdVqBwQfG9nHYbVJ0CzeAwCRXs5IeQ4GDRhW+2BMwnwfQl56M6t0C1Nu3qgLDT3l8IxQRfZJwBT20ryfS+NerorEZSB7rgPHZKQru8xPaEE/i66ekInET4OTt49DGl5T6D+ioO3Z9OoK3q9h3GvriFNEZNCWapC5KHPKQGrPgNobo=;EE+tqrE6/jqb+PZ42BcWww=="
---

